Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
defensin alpha 5 | 0.695 | 0.423 | 5.2E-06 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2008 | 2017 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
integrin subunit alpha 4 | 0.558 | 0.769 | 1.0E-04 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2015 | 2017 | ||||||||
|
secreted frizzled related protein 2 | 0.544 | 0.731 | 1.7E-03 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2008 | 2015 | ||||||||
|
integrin subunit alpha L | 0.511 | 0.885 | 4.3E-03 |
|
group | 0.310 | None | 1.000 | 2 | 1 | 2014 | 2017 | ||||||||
|
vanin 1 | 0.670 | 0.500 | 4.4E-06 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2006 | 2013 | ||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
secreted frizzled related protein 1 | 0.479 | 0.846 | 0.96 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.300 | None | 0.941 | 17 | 0 | 1993 | 2019 | ||||||||
|
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 | 0.636 | 0.692 | 1.3E-07 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
integrin subunit beta 8 | 0.650 | 0.462 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
SLAM family member 8 | 0.839 | 0.154 | 5.3E-06 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cullin 2 | 0.700 | 0.500 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
X-box binding protein 1 | 0.477 | 0.846 | 3.2E-02 |
|
group | 0.270 | None | 0.857 | 7 | 1 | 2008 | 2020 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.260 | None | 0.857 | 7 | 1 | 2004 | 2019 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
group | 0.260 | None | 1.000 | 6 | 0 | 1996 | 2019 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.250 | None | 1.000 | 6 | 0 | 2003 | 2019 | ||||||||
|
RUNX family transcription factor 3 | 0.459 | 0.731 | 0.84 |
|
group | 0.230 | None | 0.667 | 3 | 0 | 2004 | 2011 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 1999 | 2017 | ||||||||
|
nuclear factor, interleukin 3 regulated | 0.633 | 0.615 | 0.82 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.200 | None | 1.000 | 17 | 1 | 2000 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
group | 0.200 | None | 0.941 | 17 | 3 | 2011 | 2018 | ||||||||
|
solute carrier family 22 member 4 | 0.603 | 0.769 | 1.8E-08 |
|
group | 0.200 | None | 0.941 | 17 | 3 | 2005 | 2018 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
group | 0.200 | None | 1.000 | 12 | 1 | 2000 | 2020 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
group | 0.200 | None | 0.909 | 11 | 2 | 1998 | 2015 |